MEDP vs NYT

Comparison between Medpace Holdings Inc (MEDP, Company) and New York Times Co. - Class A (NYT, Company).

MEDP is from the Healthcare sector, while NYT is from the Communication Services sector.

5-Year PerformanceMEDP has outperformed NYT, delivering a return of +20.9% compared to +13.2%

MEDP vs NYT - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MEDP(COMPANY)	NYT(COMPANY)
Market Cap	$12B	$12B
Max Drawdown	42.87%	93.35%
Sharpe Ratio	0.80	1.15
5Y Beta	1.06	0.48
Industry	Diagnostics & Research	Publishing
P/E Ratio	25.95	40.10
Forward P/E	25.71	26.74
PEG Ratio	1.33	1.10
Dividend Yield	N/A	1.04%
5Y Dividends CAGR	N/A	31.67%
5Y EPS CAGR	29.42%	24.14%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	5.90%	4.50%
P/S Ratio	4.42	4.18
P/B Ratio	20.14	6.01

Market Cap

Winner

MEDP

$12B

NYT

$12B

Max Drawdown

Winner

MEDP

42.87%

NYT

93.35%

Sharpe Ratio

MEDP

0.80

Winner

NYT

1.15

5Y Beta

MEDP

1.06

Winner

NYT

0.48

Industry

MEDP

Diagnostics & Research

NYT

Publishing

P/E Ratio

Winner

MEDP

25.95

NYT

40.10

Forward P/E

Winner

MEDP

25.71

NYT

26.74

PEG Ratio

MEDP

1.33

Winner

NYT

1.10

Dividend Yield

MEDP

N/A

NYT

1.04%

5Y Dividends CAGR

MEDP

N/A

NYT

31.67%

5Y EPS CAGR

Winner

MEDP

29.42%

NYT

24.14%

Debt to Equity

MEDP

0.00%

NYT

0.00%

Free Cash Flow Yield

Winner

MEDP

5.90%

NYT

4.50%

P/S Ratio

MEDP

4.42

Winner

NYT

4.18

P/B Ratio

MEDP

20.14

Winner

NYT

6.01

MEDP vs NYT - Historical Returns

Returns include dividend reinvestment.

Period	MEDP	NYT
1 month	+1.84%	-5.80%
3 months	-4.02%	-4.63%
6 months	-29.26%	+15.87%
1 year	+43.71%	+36.84%
5 years(CAGR)	+20.94%	+13.16%
10 years(CAGR)	+32.26%	+21.24%
Max(CAGR)	+32.26%	+3.65%

Winner

MEDP

+1.84%

NYT

-5.80%

Winner

MEDP

-4.02%

NYT

-4.63%

MEDP

-29.26%

Winner

NYT

+15.87%

Winner

MEDP

+43.71%

NYT

+36.84%

5Y(CAGR)

Winner

MEDP

+20.94%

NYT

+13.16%

10Y(CAGR)

Winner

MEDP

+32.26%

NYT

+21.24%

Max(CAGR)

Winner

MEDP

+32.26%

NYT

+3.65%

MEDP vs NYT - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	MEDP	NYT
2026	-24.85%	+7.97%
2025	+67.78%	+34.39%
2024	+8.72%	+9.61%
2023	+47.17%	+49.45%
2022	-0.89%	-32.01%
2021	+61.91%	-1.28%
2020	+67.77%	+59.84%
2019	+60.42%	+48.18%
2018	+42.51%	+18.45%
2017	+0.97%	+38.94%
2016	+29.79%	+3.55%
2015	N/A	+5.80%
2014	N/A	-14.41%
2013	N/A	+82.59%
2012	N/A	+9.78%
2011	N/A	-21.60%
2010	N/A	-24.79%
2009	N/A	+62.85%
2008	N/A	-55.78%
2007	N/A	-23.09%
2006	N/A	-7.62%
2005	N/A	-33.09%
2004	N/A	-12.34%
2003	N/A	+2.70%
2002	N/A	+6.90%
2001	N/A	+13.60%
2000	N/A	-15.52%
1999	N/A	+22.79%

MEDP vs NYT Drawdown Comparison

The maximum drawdown for MEDP was -42.87%, occurring on Apr 27, 2022. Recovery took 264 trading sessions.

The maximum drawdown for NYT was -92.10%, occurring on Feb 19, 2009. Recovery took 4527 trading sessions.

The current MEDP drawdown is -30.85%. The current NYT drawdown is -12.66%.

Rank	MEDP	NYT
#1	-42.87% Dec 27, 2021 - Jan 13, 2023	-92.10% Jun 20, 2002 - Jun 15, 2020
#2	-41.43% Dec 6, 2016 - Dec 19, 2017	-49.93% Jan 26, 2021 - Jul 22, 2024
#3	-39.47% Feb 25, 2020 - Jul 15, 2020	-31.94% Dec 28, 1999 - Mar 15, 2002
#4	-39.38% Jul 16, 2024 - Jul 22, 2025	-19.67% Nov 1, 2024 - May 29, 2025
#5	-36.61% Jan 21, 2026 - Apr 23, 2026	-19.08% Aug 5, 2020 - Dec 9, 2020
#6	-27.23% Jan 23, 2023 - Jun 30, 2023	-13.51% Apr 7, 2026 - May 21, 2026
#7	-27.15% Feb 25, 2019 - Jul 30, 2019	-11.48% Aug 6, 2025 - Nov 10, 2025
#8	-26.31% Sep 18, 2018 - Dec 3, 2018	-9.67% May 30, 2025 - Aug 6, 2025
#9	-26.07% Dec 3, 2018 - Jan 31, 2019	-9.14% Dec 31, 2020 - Jan 25, 2021
#10	-19.22% Sep 13, 2023 - Nov 14, 2023	-8.24% Feb 2, 2026 - Feb 17, 2026
#11	-18.41% Sep 17, 2019 - Jan 14, 2020	-7.58% Jul 23, 2024 - Aug 27, 2024
#12	-18.36% Apr 26, 2021 - Sep 3, 2021	-6.17% Nov 10, 1999 - Dec 2, 1999
#13	-18.12% Sep 2, 2020 - Dec 1, 2020	-5.64% Dec 14, 1999 - Dec 28, 1999
#14	-17.99% Feb 26, 2018 - May 7, 2018	-5.32% May 16, 2002 - Jun 18, 2002
#15	-12.03% Nov 24, 2025 - Jan 21, 2026	-5.30% Aug 27, 2024 - Sep 17, 2024